76603-21-9 Usage
Chemical structure
A complex structure containing a pyrido-1,2,4-triazine ring, a phenyl group, and a 1-oxopropyl group.
Phenyl group attachment
The phenyl group is attached to the pyrido-1,2,4-triazine ring.
1-Oxopropyl group connection
The 1-oxopropyl group is connected to the ring at the 1,2-dihydro position.
Potential applications
Possible uses in pharmaceuticals or materials science, but further research and investigation are needed.
Reactivity
May have specific reactivity due to its intricate structure.
Solubility
Specific solubility properties that need to be considered in applications or research.
Chemical characteristics
Other chemical characteristics, such as stability and reactivity with other compounds, should be carefully considered.
Further research
The exact uses and properties of this compound require additional research and investigation.
Check Digit Verification of cas no
The CAS Registry Mumber 76603-21-9 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 7,6,6,0 and 3 respectively; the second part has 2 digits, 2 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 76603-21:
(7*7)+(6*6)+(5*6)+(4*0)+(3*3)+(2*2)+(1*1)=129
129 % 10 = 9
So 76603-21-9 is a valid CAS Registry Number.
InChI:InChI=1/C15H14N4O/c1-2-14(20)19-13-8-9-16-10-12(13)17-15(18-19)11-6-4-3-5-7-11/h3-10H,2H2,1H3,(H,17,18)
76603-21-9Relevant articles and documents
Pyrido?3,4-e!-as-triazines
-
, (2008/06/13)
Acylated pyrido ?3,4-e!-as-triazines of the formula (I), STR1 wherein R1 stands for alkyl, alkoxy, haloalkyl, furyl, pyridyl, phenyl, phenyl-(C1-4 alkyl) or phyenyl-(C2-4 alkenyl) optionally substituted. R2 stands for hydrogen or a group of the formula R1 --CO--, R3 stands for hydrogen, a phenyl group or a naphthy6l group optionally substituted, or a phenyl-(C1-4 alkyl) group, pyridyl group or a C1-20 alkyl group, and R4 stands for hydrogen or a group of the formula R1 --CO--, and R5 forms together with R2 or R4 a valence bond, wherein R2 or R4 taking part in forming said valence bond may not have the above meaning, and pharmaceutically acceptable acid addition salts thereof, which are prepared by reacting a pyrido ?3,4-e!-as-triazine of the formula (II) or an acid addition salt thereof STR2 R6 stands for hydrogen, and R5 forms together with R and R4 a valence bond, with an acylating agent of the formula (III). The compounds exert favourable effects on the central nervous system, and can be applied primarily as analgesic and antiphlogistic agents.